Ravoxertinib Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage through Early Inhibition of Erk1/2
- Type
- Retraction
- Notice date
- 6/4/2024 0:00
- Journal
- ACS Omega
- Publisher
- American Chemical Society (ACS)
- Notice DOI
- 10.1021/acsomega.4c03199
- Original paper DOI
- 10.1021/acsomega.3c01296